TokenPost·
Kura Oncology Receives $55 Million Under Oberland Capital Agreement
The agreement provides up to $300 million in potential funding, subject to conditions. Kura plans a roughly 40-patient darlifarnib study in the first half of 2027.
More news
- CoinGapeAnthropic IPO Targets To Raise Whopping $90 Billion As SpaceX Stock Continues Crash
- TokenPostEther (ETH) Spot ETFs Post $1.32 Million Outflow for Fourth Straight Day
- TokenPostBitcoin Spot ETFs Record $95 Million Outflow for Fourth Straight Day
- TokenPostTaiwan Suppliers Forecast to Ship 88.9% of Servers in Q4
- TokenPostPublic Service Company of New Mexico Sets $1.145 Preferred Dividend Per Share
- Crypto BriefingClaude Fable 5.2 tops new life-science image benchmark as tool use nearly doubles scores